A Phase 2 Dose Ranging Randomized Double Blind and Placebo-Controlled Study Evaluating the Safety Tolerability Pharmacokinetics and Efficacy of EDP-305 in Subjects with Non-alcoholic Steatohepatitis (NASH)
Brief description of study
A randomized, double-blind study to assess the safety, tolerability, PK and efficacy of EDP-305 in subjects with Non-Alcoholic Steatohepatitis
Clinical Study Identifier: s17-01518
ClinicalTrials.gov Identifier: NCTs17-01518
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
